2021International Journal of Pharmaceutical Sciences Review and ResearchOpen access

Review on Rosuvastatin and Fenofibrate

Devendra Singh, Kiruthiga Shankar Kumar, Nupur Mahadeokar

Open full text 0 citations

Abstract

This article is an examination of a review on Rosuvastatin and Fenofibrate. The scientific development and subsequent study of the effects that Rosuvastatin and Fenofibrate have, which taken individually and in combination, on various diseases, continues to influence the researchers all over the globe today. This article examines the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries and demonstrates further aspects of Rosuvastatin and Fenofibrate. Additionally, this article explores the effect that rosuvastatin has on thromboinflammation, platelet volume and dyslipidaemia, the effects of Fenofibrate on diabetic retinopathy, non-alcoholic fatty liver disease and dyslipidaemia and finally the combined effects of rosuvastatin and fenofibrate on prostate cancer, Ischemic stroke and hypolipidemia.

Open-access reader

About this research paper

What this paper is about

This article is an examination of a review on Rosuvastatin and Fenofibrate. The scientific development and subsequent study of the effects that Rosuvastatin and Fenofibrate have, which taken individually and in combination, on various diseases, continues to influence the researchers all over the globe today. This article examines the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries and demonstrates further aspects of Rosuvastatin and Fenofibrate. Additionally, this article explores the effect that rosuvastatin has on thromboinflammation, platelet volume and dyslipidaemia, the effects of Fenofibrate on diabetic retinopathy, non-alcoholic fatty liver disease and dyslipidaemia and finally the combined effects of rosuvastatin and fenofibrate on prostate cancer, Ischemic stroke and hypolipidemia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This article is an examination of a review on Rosuvastatin and Fenofibrate. The scientific development and subsequent study of the effects that Rosuvastatin and Fenofibrate have, which taken individually and in combination, on various diseases, continues to influence the researchers all over the globe today. This article examines the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries and demonstrates further aspects of Rosuvastatin and Fenofibrate. Additionally, this article explores the effect that rosuvastatin has on thromboinflammation, platelet volume and dyslipidaemia, the effects of Fenofibrate on diabetic retinopathy, non-alcoholic fatty liver disease and dyslipidaemia and finally the combined effects of rosuvastatin and fenofibrate on prostate cancer, Ischemic stroke and hypolipidemia.

Key concepts: Fenofibrate, Rosuvastatin, Medicine, Internal medicine, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Review on Rosuvastatin and Fenofibrate — Research Paper | ScholarLens